Ludovic Peeters work email
- Valid
- Valid
Ludovic Peeters personal email
Currently heading a Development Unit (10 people) in charge of End-to-end Vaccines Drug Substance process development from Phase I to Phase III. 10+ years of experience in industrial biotechnology including process characterization and development, scale-up, life cycle support, technology transfer (international) of viral vaccines production (incl. microcarriers-based processes). 6 years of hands-on experience with single-use bioreactors. Evaluation of different technologies. Troubleshooting.Collaborative technology development with suppliers. Development and use of modeling tools for final scale process cost estimate, production schedule, total capacity estimation, … Mixing and aeration performances characterization in bioreactors (incl. single-use bioreactors) and creation of scale-up strategies up to 1000L. New technologies evaluation for vaccines manufacturing : perfusion devices for cell culture, single-use centrifuge systems, chromatography systems, … Team management and transversal collaborations to support technological activities and upstream process development.
Gsk Vaccines
-
Associate Director - Dev Unit Head - Drug SubstanceGsk Vaccines Apr 2020 - PresentLeading a team of Upstream and Downstream scientists and technicians in charge of Drug Substance process development from Phase I to Phase III.
-
Expert Scientist - Technical R&D Drug SubstanceGsk Vaccines Apr 2016 - Apr 2020Transversal role to support upstream activities.Consolidation of bioreactor scale-up and scale-down models.Responsible for maintaining best practices in the upstream part of the process.
-
Scientist - New Product DevelopmentGsk Vaccines Apr 2013 - Mar 2016- In charge of final process development, scale-up, process evaluation of a microcarrier-basedviral process (4 serotypes).- Responsible of a team of 7 technicians working with single-use bioreactors ranging from 2L up to 200L.- Leader of the 5S initiative within development labs to optimize ways of working.- Use of the Quality by Design principles for process development and consolidation.- Creation of the full Documentation Package (Process History Files) summarizing 3 years of final process development.
-
Scientist - Industrialization New TechnologiesGsk Vaccines Sep 2011 - Mar 2013Technical support provided to commercial manufacturing teams to increase productivityusing new technologies:- Single-Use Centrifuges (kSep, Unifuge) applied to an adherent cells live viral vaccine process- Filter – Dryer / Nutsche filters applied to a polysaccharide-based vaccine process- Chromatography media applied to purification of a whole-virus vaccine
-
Scale-Up Engineer - Industrialization New TechnologiesGlaxosmithkline Biologicals Jan 2009 - Aug 2011- In charge of the evaluation, selection and implementation of Single-Use Bioreactors as new technology platform for vaccines process development activities.- Management of 3 technicians to perform middle-scale (200L) cell cultures and viral production using an Animal-Free VERO cells process.- Technologies evaluated: Hyclone (part of Thermofisher), Sartorius, Xcellerex (now part of GE Healthcare), ATMI (now part of Pall).- Numerous interactions with all suppliers for technical and business matters.- Construction of transversal team to identify the most suitable single-use bioreactor technology for GSK (procurement, engineering, QA, EHS, automation ...).
-
Scale-Up Engineer - Industrialization Viral BulkGlaxosmithkline Biologicals Jan 2008 - Dec 2008Responsible for microcarrier-based cell culture process transfer from Belgium to a GSK based facility (non-GMP activities). Activities were continued with the participation to further process development.
-
Scale-Up Engineer - Industrialization Cell CultureGlaxosmithkline Biologicals Oct 2006 - Jan 2008In charge of scale-up and scale-down modelization for cell culture application. Creation ofmathematical models to predict mixing and aeration performances in cell culture bioreactors. Expertrole with transversal interactions to support numerous cell-based vaccines process development.Complete revamping of a fully automated 600L stainless steel bioreactor, including deepanalysis of both software (review of all recipe steps) and hardware (detailed review of P&ID) aspects.
-
StudentGlaxosmithkline Biologicals Feb 2006 - Sep 2006Mixing performance characterization and scale-up strategy definition for microcarrier-based cell culture process.
Ludovic Peeters Skills
Ludovic Peeters Education Details
-
University Of Liège(Bio)Chemical Engineering
Frequently Asked Questions about Ludovic Peeters
What company does Ludovic Peeters work for?
Ludovic Peeters works for Gsk Vaccines
What is Ludovic Peeters's role at the current company?
Ludovic Peeters's current role is Associate Director - Drug Substance at GSK Vaccines.
What is Ludovic Peeters's email address?
Ludovic Peeters's email address is lu****@****bio.com
What schools did Ludovic Peeters attend?
Ludovic Peeters attended University Of Liège.
What skills is Ludovic Peeters known for?
Ludovic Peeters has skills like Cell Culture, Project Management, Troubleshooting, Process Engineering, Process Development, Disposables, Bioreactor Design, Sap, External Scientific Collaboration, Mixing, Microsoft Office, People Management.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial